Limited availability of information on antibiotics and lack of availability of appropriate antibiotics were cited as important challenges for appropriate antibiotic selection.
While incidence of community-associated and healthcare-associated community-onset MRSA bacteremia declined during the pandemic, hospital-onset cases rose substantially.
Antibiotic use in the first 3 month of life was associated with a 23% increase in risk of early puberty in girls.
A study of bloodstream infections in Ontario finds attributable mortality due to AMR over 5 years was 896 deaths, or 1.2 per 100,000 population per year.
The AMR Industry Alliance has updated its Antibiotic Manufacturing Standard to be more aligned with WHO antibiotic manufacturing guidelines.
The median treatment duration for uncomplicated gram-negative BSIs at 24 US hospitals was 11 days, with marked variation among hospitals.
Analysis of hospitalized patients with community-acquired pneumonia links azithromycin to lower mortality and more hospital-free days compared with doxycycline in combination with beta-lactams.
